Literature DB >> 17215450

Beta-arrestin signaling and regulation of transcription.

Lan Ma1, Gang Pei.   

Abstract

Beta-arrestin 1 and beta-arrestin 2 are well-known negative regulators of G-protein-coupled receptor (GPCR) signaling. Upon GPCR activation, beta-arrestins translocate to the cell membrane and bind to the agonist-occupied receptors. This uncouples these receptors from G proteins and promotes their internalization, thus causing desensitization. However, accumulating evidence indicates that beta-arrestins also function as scaffold proteins that interact with several cytoplasmic proteins and link GPCRs to intracellular signaling pathways such as MAPK cascades. Recent work has also revealed that, in response to activation of certain GPCRs, beta-arrestins translocate from the cytoplasm to the nucleus and associate with transcription cofactors such as p300 and cAMP-response element-binding protein (CREB) at the promoters of target genes to promote transcription. They also interact with regulators of transcription factors, such as IkappaBalpha and MDM2, in the cytoplasm and regulate transcription indirectly. This beta-arrestin-mediated regulation of transcription appears to play important roles in cell growth, apoptosis and modulation of immune functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17215450     DOI: 10.1242/jcs.03338

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  103 in total

1.  Yin Yang 1 phosphorylation contributes to the differential effects of mu-opioid receptor agonists on microRNA-190 expression.

Authors:  Hui Zheng; Ji Chu; Yan Zeng; Horace H Loh; Ping-Yee Law
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

Review 2.  Opioid receptor trafficking and signaling: what happens after opioid receptor activation?

Authors:  Jia-Ming Bian; Ning Wu; Rui-Bin Su; Jin Li
Journal:  Cell Mol Neurobiol       Date:  2011-09-25       Impact factor: 5.046

Review 3.  Beyond desensitization: physiological relevance of arrestin-dependent signaling.

Authors:  Louis M Luttrell; Diane Gesty-Palmer
Journal:  Pharmacol Rev       Date:  2010-04-28       Impact factor: 25.468

4.  Stromal expression of β-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer.

Authors:  Katja Lundgren; Nicholas P Tobin; Sophie Lehn; Olle Stål; Lisa Rydén; Karin Jirström; Göran Landberg
Journal:  J Mol Diagn       Date:  2011-05       Impact factor: 5.568

Review 5.  Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors.

Authors:  Louis M Luttrell
Journal:  Mol Biotechnol       Date:  2008-02-01       Impact factor: 2.695

Review 6.  Molecular basis of lysophosphatidic acid-induced NF-κB activation.

Authors:  Wenjing Sun; Jianhua Yang
Journal:  Cell Signal       Date:  2010-05-12       Impact factor: 4.315

7.  S-Nitrosylation of β-Arrestins Biases Receptor Signaling and Confers Ligand Independence.

Authors:  Hiroki Hayashi; Douglas T Hess; Rongli Zhang; Keiki Sugi; Huiyun Gao; Bea L Tan; Dawn E Bowles; Carmelo A Milano; Mukesh K Jain; Walter J Koch; Jonathan S Stamler
Journal:  Mol Cell       Date:  2018-05-03       Impact factor: 17.970

8.  Nuclear βArrestin1 regulates androgen receptor function in castration resistant prostate cancer.

Authors:  Hamsa Thayele Purayil; Yushan Zhang; Joseph B Black; Raad Gharaibeh; Yehia Daaka
Journal:  Oncogene       Date:  2021-03-10       Impact factor: 9.867

Review 9.  Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER.

Authors:  Eric R Prossnitz; Matthias Barton
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-05-13       Impact factor: 3.072

Review 10.  Agonist-selective signaling of G protein-coupled receptor: mechanisms and implications.

Authors:  Hui Zheng; Horace H Loh; Ping-Yee Law
Journal:  IUBMB Life       Date:  2010-02       Impact factor: 3.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.